Introducing the next 10 years as ICR Consilium: staying true to our values
In a new ICR Consilium Conscience blog, Senior Partner Amber Fennell reflects on how ICR Consilium’s commitment to our values has led to our success in the last 10 years as a global leader in strategic healthcare communications, and will continue to do so in the future as part of the ICR group.
LinkConsilium’s Acquisition by our long-standing JV Partner, ICR By Mary-Jane Elliott
Today we have announced the sale of Consilium to our long-term JV partner and the leading US investor relations and communications firm @ ICR. We are extremely excited by our next phase of growth, under ICR’s ownership.
LinkGreat teamwork: Thank you! By Mary-Jane Elliott
Having advised on the communications of so many deals over our careers, it also feels exciting to have done one of our own, especially when the strategic and cultural fit is so strong. As with any deal there are so many people to thank.
LinkReflections of advising a client over a 10 year period
As Consilium celebrated its 10th anniversary, Chris Welsh, reflected on his experiences as an advisor at Consilium, with a focus on the growth and success over the years for one of our clients, MaxCyte, sharing his thoughts on how he has navigated and adapted to changes over the last decade, both to the way we work and the markets we operate in.
LinkConsilium celebrates a strong first decade
Ten years ago today, on 25 July 2013, Consilium was launched by Mary-Jane Elliott and Amber Fennell and colleagues. Fast forward to now, and we have grown into a highly driven, market-leading team of more than 40 people and a truly international network of advisors. Our Managing Partner Mary-Jane Elliott reflects in her latest blog on how positive thinking has been key on Consilium’s journey to success.
LinkASCO: bringing mental health into cancer care
Paul Thambi MD, Chief Medical Officer and Co-founder of Sunstone Therapies, is a regular attendee at ASCO’s June conference. On his 10th visit this year, he considers how the conference is changing to reflect patient needs and how this will begin to improve patient care.
LinkGreen shoots on the Emerald Isle
Dublin gave a characteristically warm welcome to this year’s BioEquity, the best-attended event in the history of the forum, according to organisers. Representatives of the life sciences sector descended on the Irish capital in early May for a dizzying schedule of partnering speed dates and panels and a little bit of well-deserved craic.
LinkPeople are demanding better treatments for mental illness – and companies are responding
The World Health Organization (WHO) states that “The need for action on mental health is indisputable and urgent”. In its 2022 World Mental Health Report, the WHO estimates that at least 13% of the global population suffers with a mental health disorder.
LinkCracking the Code: The importance of effective communication in genetic research
Evi Useh, Account Executive, reflects on how her educational background in medical genetics and cell and gene therapy is allowing her to support our clients who are applying genetic understanding to develop innovative medicines. Here at Consilium we are proud to help our clients translate their complex science in a way that can be understood by various audiences including investors, researchers and patients.
LinkInsights from Advanced Therapies 2023: Leveraging communications for better outcomes
Just 24 hours after the hastily arranged sale of SVB UK to HSBC hit the headlines, representatives from the world of cell and gene therapy development came together in London for the Advanced Therapies Congress – Europe’s largest cell and gene therapy conference and exhibition.
Link